Literature DB >> 34715321

Selective Intra-Arterial Lutetium-177-Labeled Prostate-Specific Membrane Antigen Therapy for Castration-Resistant Prostate Cancer: Initial Results.

Haluk B Sayman1, Fatih Gulsen2, Sait Sager1, Elife Akgun1, Nami Yeyin1, Seckin Bilgic1, Kubra N Toplutas1, Feifei An3, Fatih Beytur1, Rahmi Oklu4, Omer Aras5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34715321      PMCID： PMC9432480          DOI： 10.1016/j.jvir.2021.10.016

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.682


× No keyword cloud information.
  3 in total

1.  Pharmacokinetics of intra-arterial tumour therapy. An experimental study.

Authors:  J von Scheel; G Golde
Journal:  Arch Otorhinolaryngol       Date:  1984

2.  Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.

Authors:  Clemens Kratochwil; Frederik L Giesel; Ruben López-Benítez; Nadine Schimpfky; Kirsten Kunze; Michael Eisenhut; Hans-Ulrich Kauczor; Uwe Haberkorn
Journal:  Clin Cancer Res       Date:  2010-05-11       Impact factor: 12.531

3.  Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial).

Authors:  Sander C Ebbers; Arthur J A T Braat; Adriaan Moelker; Marcel P M Stokkel; Marnix G E H Lam; Maarten W Barentsz
Journal:  Trials       Date:  2020-02-05       Impact factor: 2.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.